Axon Enterprise, Inc
Axon Enterprise, Inc (NASDAQ: AXON) is a technology company focused on global public safety, dedicated to developing public safety operating systems. The company combines a range of hardware devices with cloud-based software solutions to support and modernize law enforcement practices.

Positive Growth Aspects
Growth Challenges
Technical Observation (on the daily chart):
AXON is in a strong uptrend, trading above both its 21-day and 50-day moving averages, which confirms bullish momentum. With an RSI around 66, AXON is nearing overbought territory with potential upside further. While the trend remains positive, traders should watch for potential consolidation or resistance at recent highs.


Axon delivered a strong Q1 2025 performance, with record revenue of USD 604 million driven by robust growth in Software & Services (up 39%) and continued demand for Connected Devices like TASER 10 and Axon Body 4. The company’s annual recurring revenue surged 34% to USD 1.1 billion, and gross margins improved, supported by a higher software mix. However, profitability was tempered by significant stock-based compensation expenses, leading to an operating loss despite solid adjusted EBITDA growth. While Axon raised its full-year revenue and EBITDA guidance, margin pressures in Connected Devices and modest free cash flow highlight the challenge of balancing rapid innovation and hardware expansion with cost discipline and cash generation.
As per the above-mentioned price action, recent key business and financial updates, momentum in the stock over the last month, and technical indicators analysis, a ‘Watch’ rating has been given to Axon Enterprise, Inc (NASDAQ: AXON) at the closing market price of USD 780.63 as of June 13,2025.
Individuals can evaluate the stock based on the support and resistance levels provided in the report in case of keen interest taking into consideration the risk-reward scenario.
Markets are trading in a highly volatile zone currently due to certain macro-economic issues and prevailing geopolitical tensions. Therefore, it is prudent to follow a cautious approach while investing.
Related Risk: This report may be looked at from a high-risk perspective and a recommendation is provided for a short duration. This report is solely based on technical parameters, and the fundamental performance of the stocks has not been considered in the decision-making process. Other factors which could impact the stock prices include market risks, regulatory risks, interest rates risks, currency risks, social and political instability risks etc.
Note 1: Past performance is not a reliable indicator of future performance.
Note 2: The reference date for all price data, currency, technical indicators, support, and resistance level is June 13,2025. The reference data in this report has been partly sourced from REFINITIV.
Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.
Note 4: Target Price refers to a price level that the stock is expected to reach as per the relative valuation method and or technical analysis taking into consideration both short-term and long-term scenarios.
Note 5: ‘Kalkine reports are prepared based on the stock prices captured either from the New York Stock Exchange (NYSE), NASDAQ Capital Markets (NASDAQ), and or REFINITIV. Typically, all sources (NYSE, NASDAQ, or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.
Disclaimer This report has been issued by Kalkine New Zealand Limited (FSP691351) (NZBN:9429047678101) (“Kalkine”). Kalkine is a Financial Advice Provider (“FAP”) and is authorised by a Class 1 Financial Advice Provider Licence issued by Financial Markets Authority (“FMA”) to provide financial advice. Kalkine provides only general financial advice through its research reports following a person becoming a member. The reports contain buy/sell/hold and other recommendations in relation to equity securities, managed funds and other managed investment schemes and other financial advice products. The recommendations and opinions in this report and on Kalkine website do not take into account any of your investment objectives, financial situation or needs. Before you make a decision about whether to acquire a financial product, you should obtain the Product Disclosure Statement from the product issuer. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. If you act on the advice in the research reports, you may have to pay fees, expenses or other amounts (but not to Kalkine). Further information about the complaints and dispute resolution process, as well as information about Kalkine’s duties are available on Kalkine’s website. Please read our Financial Advice Provider (FAP) disclosure statement and Complaints Handling Guide, which are available on the website.
Past performance is not a reliable indicator of future performance.